Skip to content

Search

Showing results for "1"

Scientific Forum Agenda

Virtual Scientific Launch Day: Wednesday 1 December 2021 (Australia) Time: 7am Australian WST/ 10am Australian EDST / 12pm NZ DST North America:

CGM with remote monitoring makes for happy families

Parents of young children with type 1 diabetes experience significantly better quality of life and reduced fear of hypoglycaemic episodes when given remote access to their child's continuous glucose monitoring, new Children's Diabetes Centre research has found.

Gifted pump proves a life changer for family

Oliver Bowman is too young to understand the enormity of having type 1 diabetes but his young parents Brooke and Aidan know all too well the reality of having a child with a chronic disease.

Insulin pumps give better glycaemia outcomes for children than MDI

Children with type 1 diabetes using an insulin pump have better glycaemic control than to those using multiple daily injections (MDI) of insulin, a new Children's Diabetes Centre study has found.

Getting the most out of the CGM scheme

If your child/adolescent has been approved to use CGM but decides they do not want to use it, it is important to complete a NDSS change/termination form, which needs to be returned to your clinic team.

Healthy holiday habits

The school holidays and Christmas are a welcome break for most families but the lack of routine can prove a trying time for families living with Type 1 Diabetes

Increasing independence in daily living tasks

In this blog, Occupational Therapy Clinical Lead Marie Rodatz shares top tips for developing independence with daily living skills —bathing or showering, washing hands, brushing teeth and dressing — in children.

Embrace research presented at SMHR conference

Associate Professor Bep Uink and Head of Kulunga Aboriginal Unit Cheryl Bridge watched on by Associate Professor Yael Perry at the SMHR conference.

Trajectories of prematurity-associated lung disease: lifelong lung health

Preterm birth is increasingly recognised as adversely influencing lifelong lung function. This Series paper on prematurity-associated lung disease reviews studies reporting longitudinal lung function measurements in individuals who were born preterm. Evidence suggests that preterm birth alters lung function trajectories from early life onwards, with implications for future respiratory morbidity. We propose that this population needs rigorous follow up that should include systematic monitoring of lung function across the lifespan, starting in childhood.

Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1

Rishi S. Kotecha MB ChB (Hons) MRCPCH FRACP PhD Co-Head, Leukaemia Translational Research rishi.kotecha@health.wa.gov.au Co-Head, Leukaemia